Medical Care in China

glioma
Treatment in China

Provide a clear and complete coordinated pathway from expert assessment to treatment and rehabilitation.

Get a Care Plan and Cost Estimate
Neurology and neurosurgery work togetherto develop a treatment plan based on the patient's condition.
Precise neurological diagnosiscombines imaging, electrophysiology, and laboratory tests.
Complex disease treatmentcovers cerebrovascular diseases, epilepsy, Parkinson's disease, and neuro-oncology.
Functional recovery supportcombined with rehabilitation therapy promotes the recovery of motor and cognitive functions.

Condition Guide

About glioma

Understand the condition, common triggers and treatment options that may require specialist assessment.

Disease Introduction

Gliomas are the most common primary malignant brain tumors originating from glial cells in the brain. They are classified according to their malignancy as low-grade (WHO grade 2) to high-grade (glioblastoma grade 4). Common symptoms include chronic headaches, seizures, limb weakness, or personality changes. Treatment is based on safe, maximum surgical resection combined with postoperative radiotherapy and chemotherapy (temozolomide). In recent years, new approaches have emerged, such as molecularly subtype-based medication, tumor-treating fields (TTFields) therapy, anti-angiogenic drugs, and immunotherapy, leading to continuous improvement in overall treatment efficacy.

Cutting-edge high-precision diagnostic and treatment technologies

  1. Vorasidenib : The first oral targeted drug for low-grade gliomas with IDH1/2 mutations. The FDA approved it in August 2024 for patients with IDH-mutant grade 2 astrocytomas or oligodendrogliomas after surgery. The pivotal INDIGO trial reduced the risk of disease progression or death by 61% compared to placebo.
  2. Tumor electric field therapy : The mid-frequency electric field output by the head-mounted transducer interferes with tumor cell division. The imported Epton was approved by the NMPA in May 2020 for use in combination with temozolomide to treat newly diagnosed glioblastoma. The median progression-free survival was 6.7 months compared to 4.0 months in the control group.
  3. Domestic electric field therapy system launched : In December 2025, China's first independently developed glioma tumor electric field therapy system was approved by the NMPA. Led by Beijing Tiantan Hospital, it is expected to further improve efficacy and reduce costs.
  4. Bevacizumab : The FDA approved bevacizumab for the treatment of recurrent glioblastoma as early as 2009. It is now one of the first-line treatments for recurrent GBM in the NCCN guidelines and can be used as a monotherapy or in combination with temozolomide.
  5. Dendritic cell vaccine : The median overall survival for newly diagnosed GBM in the DCVax-L trial was 23.4 months, compared to approximately 15 months in historical controls; the 12-month overall survival rate of the next-generation DC vaccine DOC1021 reached 88%.

Care Overview

glioma Treatment in China

The medical team will develop a personalized protocol based on the pathology type, stage, genetic test, previous treatment history, and the patient's physical condition.

Leading Specialists

Trusted Expertise Across Leading Specialties

Gu Yuxiang

Chief Physician, Professor, Doctoral Supervisor, Director of Cerebrovascular Disease Subspecialty

Neurology

-Research areas : Cerebrovascular diseases, Moyamoya disease, intracranial aneurysms; - Areas of expertise: cerebrovascular complex surgery, intracranial and extracranial vascular bypass, FLOW00 intraoperative perfusion assessment; - Areas of expertise: Intracranial aneurysm, cerebral AVM, Moyamoya disease, spontaneous intracerebral hemorrhage; - Academic Highlights & Core Values: Innovative "Huashan Solution" for cerebrovascular composite surgery; Leading expert in surgical diagnosis and treatment of moy

Huashan Hospital Affiliated to Fudan University logo Affiliated Hospital Huashan Hospital Affiliated to Fudan University
Yuan Ying

Associate Chief Physician

Neurology

Research areas : neurogenic dysphagia, aphasia, cognitive rehabilitation; cutting-edge technology: stepwise rehabilitation for dysphagia after stroke; areas of expertise: dysphagia after brain injury, dysarthria, cognitive and memory decline; academic highlights: authoritative expert in speech and cognitive rehabilitation; core value: establishing screening and rehabilitation pathways for neurogenic swallowing and language disorders to reduce the risk of aspiration.

Xuanwu Hospital (First Clinical Medical College), Capital Medical University logo Affiliated Hospital Xuanwu Hospital (First Clinical Medical College), Capital Medical University
Wu Yi

Chief Physician, Professor, Doctoral Supervisor, Director of the Department of Rehabilitation Medicine , and Director of the Department of Rehabilitation Medicine, Shanghai Medical College of Fudan University.

Neurology

Research Areas : Rehabilitation assessment and treatment of functional impairments after stroke; rehabilitation treatment of hemiplegia due to stroke/traumatic brain injury, paraplegia due to spinal cord injury, altered consciousness, aphasia, and dysphagia. Cutting-Edge Technologies: Innovatively proposed the concept of "precise positioning, precise diagnosis, and precise rehabilitation," pioneering the integration of imaging, neurophysiology, and near-infrared brain function detection technologies into

Huashan Hospital Affiliated to Fudan University logo Affiliated Hospital Huashan Hospital Affiliated to Fudan University
Lu Jiahong

Chief Physician, Professor, Doctoral Supervisor, Director of the Neuroimmunology/Myopathy Subspecialty

Neurology

-Research areas : Myasthenia gravis, inflammatory myopathy, autoimmune encephalitis; - Areas of expertise: Neuromuscular antibody profiling, individualized immune modulation for myasthenia gravis, plasma exchange/immunoadsorption therapy; - Diseases specializing in: Myasthenia gravis, polymyositis, dermatomyositis, autoimmune encephalitis, neuromyelitis optica spectrum disorders; - Academic Highlights & Core Values: A leading authority on neuroimmunological diseases in China, the author of the national gu

Huashan Hospital Affiliated to Fudan University logo Affiliated Hospital Huashan Hospital Affiliated to Fudan University
Cheng Xin

Chief Physician, Professor, Doctoral Supervisor, Deputy Director of the Department of Neurology, Huashan Hospital.

Neurology

Research areas : Acute treatment of cerebrovascular diseases and clinical and basic research on cerebral small vessel diseases. Cutting-edge technology: Over 10 years of experience in managing the acute stroke green channel at Huashan Hospital; specializing in acute stroke treatment procedures, intravenous thrombolysis, endovascular therapy, and multimodal imaging assessment; leading a national key science and technology project and conducting original research on the pathogenesis of cerebral small vessel

Huashan Hospital Affiliated to Fudan University logo Affiliated Hospital Huashan Hospital Affiliated to Fudan University
Wang Yuping

Chief Physician, Professor, Doctoral Supervisor, Former Department Head

Neurology

Research areas : Epilepsy, sleep disorders, neuromodulation; Cutting-edge technologies: Magnetoencephalography (MEG) for epileptogenic focus localization, neuromodulation therapy for refractory epilepsy; Areas of expertise: All types of epilepsy, narcolepsy, restless legs syndrome; Academic highlights: Leading expert in epilepsy and sleep medicine in China; Core value: Establishing integrated diagnosis and treatment standards for epilepsy and sleep disorders in China. Su Fengzeng (Chief Physician, Profess

Xuanwu Hospital (First Clinical Medical College), Capital Medical University logo Affiliated Hospital Xuanwu Hospital (First Clinical Medical College), Capital Medical University

Patient Stories

See the Next Step Through Patient Journeys

Fighting NMDAR Encephalitis - Repelling a CASE 01
PATIENT JOURNEY

Fighting NMDAR Encephalitis - Repelling a "Rare" Invasion

Neurology

Patient records Name: Aisha Khan Age: 34 Nationality: Pakistan (Karachi) Diagnosis: Anti-NMDAR encephalitis (associated with ovarian teratoma) Treatment Hospital: Peking Union Medical College Hospital, Chinese Academy of Medical Sciences – Neurology/Rheumatology/Obstetrics and Gynecology MDT Team In the video Aisha sent, she was holding her newborn baby, her face beaming with a happy and peaceful smile. In the video, she said, "Thank you for helping me fight off that 'rare' demon that almost took everyth

View case details →
Alzheimer's Disease - Unveiling the Mystery of CASE 02
PATIENT JOURNEY

Alzheimer's Disease - Unveiling the Mystery of "Forgetting"

RehabilitationNeurology

Patient records Name: David Miller Age: 68 Nationality: Australia (Melbourne) Diagnosis: Alzheimer's disease (stage of mild cognitive impairment progressing to dementia, Aβ-PET positive, ApoE ε4 carrier) Treatment Hospital: Department of Neurology, Xuanwu Hospital, Capital Medical University / National Clinical Research Center for Geriatric Diseases Mr. David's daughter sent me a video showing David sitting at the piano, playing Chopin's Nocturne with fluid grace. His eyes were focused, his fingers danc

View case details →
Primary Hemifacial Spasm - Releasing the CASE 03
PATIENT JOURNEY

Primary Hemifacial Spasm - Releasing the "Tight Band" on the Face

Neurology

Patient records Name: Tanaka Yuki Age: 55 Nationality: Japan (Fukuoka) Diagnosis: Primary hemifacial spasm (left side, 5-year course, reduced effectiveness of botulinum toxin treatment, severely affecting social life) Treatment Hospital: Department of Neurosurgery, West China Hospital of Sichuan University In the video sent by Ms. Yuki, she is dressed in an elegant kimono, smiling as she serves tea to guests in a tea ceremony classroom. Her expression is gentle and natural, with no more twitching in her l

View case details →
Drug-Refractory Temporal Lobe Epilepsy - Taming the Brain's CASE 04
PATIENT JOURNEY

Drug-Refractory Temporal Lobe Epilepsy - Taming the Brain's "Electrical Storm"

Neurology

Patient records Name: Lily Anderson Age: 28 Nationality: British (London) Diagnosis: Drug-resistant temporal lobe epilepsy (complex partial seizures, 4-5 seizures per month, MRI showing right hippocampal sclerosis) Treatment Hospital: Department of Neurosurgery, Huashan Hospital Affiliated to Fudan University Core technology: Precise anterior temporal lobectomy with brain functional area localization assistance under intraoperative awake anesthesia. In the latest video Lily sent, she stands confidently in

View case details →

Next Step

Get a Care Plan
and Cost Estimate.

Tell us about your diagnosis and needs, and our team will help screen the right hospital and explain the next steps.

Email:goldentcm@163.com

Get a Care Plan and Estimate

Once you submit your information, a member of our support team will reach out to you within one business day.